Hans Peter

5.2k total citations · 1 hit paper
69 papers, 3.3k citations indexed

About

Hans Peter is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Hans Peter has authored 69 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Rheumatology. Recurrent topics in Hans Peter's work include Immunodeficiency and Autoimmune Disorders (16 papers), T-cell and B-cell Immunology (12 papers) and Blood disorders and treatments (8 papers). Hans Peter is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (16 papers), T-cell and B-cell Immunology (12 papers) and Blood disorders and treatments (8 papers). Hans Peter collaborates with scholars based in Germany, United States and Switzerland. Hans Peter's co-authors include Klaus Warnatz, Michael Schlesier, Hermann Eibel, Ruth Dräger, Bodo Grimbacher, Ulrich Salzer, Moritz Braun, Guido Wolff-Vorbeck, Christoph Groth and Axel Denz and has published in prestigious journals such as Blood, Nature Immunology and The Journal of Immunology.

In The Last Decade

Hans Peter

67 papers receiving 3.1k citations

Hit Papers

Homozygous loss of ICOS is associated with adult-onset co... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Peter Germany 25 2.2k 711 674 353 352 69 3.3k
Jiří Litzman Czechia 31 2.1k 1.0× 675 0.9× 358 0.5× 349 1.0× 120 0.3× 105 2.8k
Manel Juan Spain 36 1.7k 0.8× 518 0.7× 380 0.6× 296 0.8× 195 0.6× 180 4.1k
Luigi D. Notarangelo Italy 24 2.4k 1.1× 679 1.0× 305 0.5× 392 1.1× 72 0.2× 41 2.9k
Francisco A. Bonilla United States 23 2.8k 1.3× 1.0k 1.5× 747 1.1× 590 1.7× 99 0.3× 33 3.5k
James Verbsky United States 28 2.9k 1.3× 647 0.9× 427 0.6× 425 1.2× 200 0.6× 81 3.8k
Massimo Fiorilli Italy 28 1.1k 0.5× 270 0.4× 219 0.3× 584 1.7× 328 0.9× 118 2.5k
V. Koneti Rao United States 27 1.7k 0.8× 462 0.6× 216 0.3× 289 0.8× 199 0.6× 87 2.8k
M. Louise Markert United States 32 2.6k 1.2× 983 1.4× 508 0.8× 929 2.6× 139 0.4× 79 4.8k
David A. Fulcher Australia 23 2.3k 1.0× 305 0.4× 168 0.2× 228 0.6× 360 1.0× 57 3.1k
Mary Ann Bonilla United States 22 1.3k 0.6× 1.7k 2.4× 345 0.5× 220 0.6× 128 0.4× 47 3.3k

Countries citing papers authored by Hans Peter

Since Specialization
Citations

This map shows the geographic impact of Hans Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Peter more than expected).

Fields of papers citing papers by Hans Peter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Peter. The network helps show where Hans Peter may publish in the future.

Co-authorship network of co-authors of Hans Peter

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Peter. A scholar is included among the top collaborators of Hans Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Peter. Hans Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sievers, Claudia, Manas K. Akmatov, Lothar Kreienbrock, et al.. (2014). Evaluation of a questionnaire to assess selected infectious diseases and their risk factors. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 57(11). 1283–1291. 17 indexed citations
2.
Salzer, Ulrich, Klaus Warnatz, & Hans Peter. (2012). Common variable immunodeficiency - an update. Arthritis Research & Therapy. 14(5). 223–223. 118 indexed citations
3.
Venhoff, Nils, Ulrich Salzer, Klaus Warnatz, et al.. (2012). Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides. PLoS ONE. 7(5). e37626–e37626. 113 indexed citations
4.
Weber, Damien C., et al.. (2010). Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study. Journal of Neuro-Oncology. 102(2). 295–300. 5 indexed citations
5.
Wasserman, Richard L., Joseph A. Church, Hans Peter, et al.. (2009). Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency. European Journal of Pharmaceutical Sciences. 37(3-4). 272–278. 43 indexed citations
6.
Bossaller, Lukas, Jan A. Burger, Ruth Draeger, et al.. (2006). ICOS Deficiency Is Associated with a Severe Reduction of CXCR5+CD4 Germinal Center Th Cells. The Journal of Immunology. 177(7). 4927–4932. 298 indexed citations
7.
Witte, Torsten, Torsten Matthias, K. Helmke, et al.. (2003). Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: comparison of 2 sets of classification criteria.. PubMed. 30(10). 2157–9. 24 indexed citations
8.
Birck, Rainer, Klaus Warnatz, Hanns M. Lorenz, et al.. (2003). 15-Deoxyspergualin in Patients with Refractory ANCA-Associated Systemic Vasculitis. Journal of the American Society of Nephrology. 14(2). 440–447. 101 indexed citations
9.
Weiner, Stefan M., Andreas Otte, Markus Uhl, et al.. (2003). Neuropsychiatrische Beteiligung des systemischen Lupus erythematodes. Medizinische Klinik. 98(2). 79–90. 8 indexed citations
10.
Weiner, Stefan M. & Hans Peter. (2002). Neuropsychiatrische Beteiligung des systemischen Lupus erythematodes. Medizinische Klinik. 97(12). 730–737. 6 indexed citations
11.
Peter, Hans, et al.. (1998). Klinik der gegenwart. 1 indexed citations
12.
Roozendaal, Caroline, A. W.M. van Milligen de Wit, Els B. Haagsma, et al.. (1998). Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. The American Journal of Medicine. 105(5). 393–399. 40 indexed citations
13.
Vaith, P., et al.. (1996). Complement Activation by C-Reactive Protein on the HEp-2 Cell Substrate. International Archives of Allergy and Immunology. 111(2). 107–117. 12 indexed citations
14.
Wistuba, Dorothee, et al.. (1994). Stereoselectivity of in vitro Isoprene Metabolism. Chemical Research in Toxicology. 7(3). 336–343. 24 indexed citations
15.
Zouboulis, Christos C., Harald Gollnick, Sabine Weber, Hans Peter, & Constantin E. Orfanos. (1991). Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies. Journal of the American Academy of Dermatology. 25(5). 882–888. 12 indexed citations
16.
Kapp, Alexander, Guido Wolff-Vorbeck, & Hans Peter. (1987). Chemiluminescence Response of Human B-Cell Lines. Free Radical Research Communications. 2(4-6). 337–341. 1 indexed citations
17.
Peter, Hans. (1983). The origin of human NK cells an ontogenic model derived from studies in patients with immunodeficiencies. Annals of Hematology. 46(5). 239–248. 8 indexed citations
18.
Peter, Hans. (1960). Die Psychiatrische Beurteilung von Motorfahrzeugführern. 2 indexed citations
19.
Peter, Hans. (1953). Zur Geschichte, Theorie und Anwendung der Kreislaufbetrachtung. Zeitschrift für schweizerische Statistik und Volkswirtschaft/Schweizerische Zeitschrift für Volkswirtschaft und Statistik/Swiss journal of economics and statistics. 89. 1–24. 2 indexed citations
20.
Peter, Hans. (1953). Mathematische Strukturlehre des Wirtschaftskreislaufes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026